Naperville, IL, United States of America

Pavel A Petukhov


 

Average Co-Inventor Count = 2.9

ph-index = 3

Forward Citations = 21(Granted Patents)


Location History:

  • Rockville, MD (US) (2010)
  • Naperville, IL (US) (2012 - 2014)
  • Chicago, IL (US) (2015)

Company Filing History:


Years Active: 2010-2015

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Pavel A. Petukhov

Introduction: Pavel A. Petukhov is a distinguished inventor based in Naperville, IL, with an impressive portfolio consisting of five patents. His work primarily focuses on the development of novel pharmaceuticals aimed at addressing significant health challenges, particularly in oncology and neurology.

Latest Patents: Among Pavel's most recent patents are two notable innovations that greatly advance the field of cancer treatment. The first patent, titled "Photoreactive Benzamide Probes for Histone Deacetylase 2," details the design, modeling, synthesis, biological evaluation, and photoaffinity labeling studies of a series of photoreactive, potent, and selective HDACs 1 and 2 benzamide-based probes. This innovation promises to enhance the understanding of histone deacetylase functions in cellular processes. The second patent, "Histone Deacetylase Inhibitors and Methods of Use Thereof," offers novel classes of HDAC inhibitors, along with methods to sensitize cancer cells to the cytotoxic effects of radiotherapy. It also includes methods for treating cancer and neurological diseases, as well as comprehensive pharmaceutical compositions and kits containing these HDAC inhibitors.

Career Highlights: Pavel A. Petukhov's career has been marked by his association with prestigious institutions, notably Georgetown University and the University of Illinois. His tenure at these universities has enabled him to contribute significantly to research, especially in the fields of pharmaceuticals and medical advancements.

Collaborations: Throughout his career, Pavel has collaborated with esteemed colleagues such as Anatoly Dritschilo and Mira Jung. These partnerships have enhanced the development and fine-tuning of his inventive concepts, furthering the impact of his work in the scientific community.

Conclusion: Pavel A. Petukhov's contributions to innovation, particularly in the realm of HDAC inhibitors and cancer treatment methods, showcase his commitment to addressing important medical challenges. With a solid foundation of patents and a history of fruitful collaborations, he remains a key figure in the field of pharmaceutical sciences.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…